Landscapes / Targets
TrkA
4 drugs act on TrkA, in 12 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs4
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Tyrosine kinase inhibitor |
Roche · Public ROG.SW |
Approved | 30 Nov 2026soonPhase 2 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | 30 Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Non-Small Cell Lung Cancer, Solid Tumors and 3 more | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Dec 2026Phase 3 trial completes | |||
| Next date | 30 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Locally Advanced Solid Tumor, Pain in Bone Metastases | ||||
| Open drug page | |||||
— |
Phase 1/2 | 25 Dec 2027Phase 1/2 trial completes | |||
| Next date | 25 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumors, Advanced Solid Tumors Harboring NTRK Fusion and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Head and Neck Carcinoma, Adenoid Cystic Carcinoma and 23 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 4 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026